Press Releases COGNOA PRESS RELEASES Cognoa Announces Nature Digital Medicine Publication of Pivotal Study Results Showing the Effectiveness of its Digital Diagnostic Device for Autism Read More » May 5, 2022 Cognoa to Present and Exhibit at the 2022 American Academy of Neurology (AAN) Annual Meeting Read More » April 4, 2022 Cognoa Named One Of Fierce Medtech’s 2022 Fierce 15 Read More » March 7, 2022 Cognoa Appoints Seasoned Financial Executive, Tony Rimac, as Chief Financial Officer Read More » September 30, 2021 Cognoa Receives FDA Marketing Authorization for First-of-its-kind Autism Diagnosis Aid Read More » June 2, 2021 Cognoa Appoints Industry Veteran Eric B. Mosbrooker as Chief Operations Officer Read More » January 13, 2021 « Previous Page1 Page2 Page3 Page4 Page5 Page6 Next » For media inquiries, please contact [email protected] Learn about our efforts to advance pediatric behavioral healthcare. Learn More
Cognoa Announces Nature Digital Medicine Publication of Pivotal Study Results Showing the Effectiveness of its Digital Diagnostic Device for Autism Read More » May 5, 2022
Cognoa to Present and Exhibit at the 2022 American Academy of Neurology (AAN) Annual Meeting Read More » April 4, 2022
Cognoa Appoints Seasoned Financial Executive, Tony Rimac, as Chief Financial Officer Read More » September 30, 2021
Cognoa Receives FDA Marketing Authorization for First-of-its-kind Autism Diagnosis Aid Read More » June 2, 2021
Cognoa Appoints Industry Veteran Eric B. Mosbrooker as Chief Operations Officer Read More » January 13, 2021
